John N. Kapoor, Director, 10% Owner at Insys Therapeutics, Inc. (INSY), bought 10,000 shares at $26.15 ($255K) on 2015-11-11, disclosed to the SEC on 2015-11-13.
Open-market purchase of $255k INSY by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.46 | 9,100 | $232K | 90.8% |
| 2 | $26.15 | 900 | $24K | 9.2% |
| Total | $25.52 avg | 10,000 | $255K | 100% |
| Filing → |
| AKRX | SELL | 2014-12-12 | $2.1M | — | Filing → |
| AKRX | SELL | 2014-08-27 | $1.9M | — | Filing → |
| INSY | BUY | 2014-06-18 | $131K | — | Filing → |